In today’s briefing:
- MicroStrategy (MSTR US): A Monetary Good Or Emperor’s New Clothes?
- Smithfield Foods (SFD): Terms Set for WH Group’s Spin-Off
- [Pre Earnings Options Flash] Halliburton’s Options Market Data Indicates Bearish Sentiment
- How JPMorgan’s Massive Investments Are Reshaping the Future of Banking! – Major Drivers
- [US Nat Gas Options Weekly 2025/03] Henry Hub Pulls Back from Uptrend on Shifting Weather Forecasts
- [US Crude Oil Options Weekly 2025/03] WTI Gained for the Fourth Straight Week on Supply Concerns
- Citigroup’s Turnaround Playbook: Core Drivers Shaping Future Performance! – Major Drivers
- Odyssey Therapeutics, Inc.(ODTX): Biotech Combating Ulcerative Colitis, or UC, Files for IPO
- Omnicom and IPG Merger of $25.6B Combined Revenue: Market Reaction and Major US Index Implications
- Quanta Services Inc (PWR) – Tuesday, Oct 22, 2024

MicroStrategy (MSTR US): A Monetary Good Or Emperor’s New Clothes?
- Microstrategy Inc Cl A (MSTR US) has a market cap of US$97.7bn, an eye-watering 115% premium to its bitcoin holding of US$45.4bn. Before taking into account debt.
- Investors are effectively dolling out $2+ for a $1 investment. And that investment is fuelled by new equity (shares are up 743% yoy) and debt. Perpetual preferred shares are next.
- Sceptics are not in short supply. But neither are backers, such as Capital (7%), Vanguard (6.9%), Susquehanna, Norges and other, arguably, sophisticated players. Right now, the backers are winning.
Smithfield Foods (SFD): Terms Set for WH Group’s Spin-Off
- Spin-Off of WH Group’s could raise up to $939 million if priced at the high-end of the range
- The IPO is set to price on Monday January 27th for a Tuesday, January 28th debut
- Flash numbers revealed sales for the three months ended December 29, 2024 will range from $3,873 million to $3,953 million (prev. year $3,998 million)
[Pre Earnings Options Flash] Halliburton’s Options Market Data Indicates Bearish Sentiment
- Halliburton will report its Q4 earnings on 22/Jan, with revenue and EPS projected to fall sequentially and annually. For fiscal 2024, revenue and net profit are expected to drop.
- Halliburton’s OI PCR at 1.21, signalling bearish sentiment, with a 67% IV percentile indicating moderately high volatility.
- For the 24/Jan expiry, Halliburton’s OI shows calls concentrated at strikes 28.5, 29, and 30. Puts dominate at 26, 27, and 27.5. Put OI is higher at key levels.
How JPMorgan’s Massive Investments Are Reshaping the Future of Banking! – Major Drivers
- JPMorgan Chase & Co.’s latest financial results reveal a robust performance for the fourth quarter of 2024.
- The firm reported net income of $14 billion with earnings per share (EPS) of $4.81 on revenue of $43.7 billion, reflecting a year-on-year revenue increase of 10%.
- The return on tangible common equity (ROTCE) was a solid 21%.
[US Nat Gas Options Weekly 2025/03] Henry Hub Pulls Back from Uptrend on Shifting Weather Forecasts
- For the week ending 17/Jan, U.S. natural gas prices declined 1% amid volatility driven by shifting weather forecasts, increasing LNG exports, and falling inventories.
- Henry Hub Put/Call volume ratio fell to 1.18 from 1.29 (10/Jan) the previous week as call volumes dropped by 5.1% WoW, while put volumes declined by 13.5%.
- Henry Hub OI PCR stayed put at 0.92 from last week. Call OI inched up by 6.9% WoW, while put OI increased by 7.4%.
[US Crude Oil Options Weekly 2025/03] WTI Gained for the Fourth Straight Week on Supply Concerns
- WTI futures rose 1.7% for the week ending 17/Jan, driven by healthy U.S. economic data, falling crude inventories, and supply concerns.
- WTI options Put/Call volume ratio surged to 1.28 from 0.83 (10/Jan) last week, as call volume fell by 70.7% WoW while put volume decreased by 54.7%.
- WTI OI PCR rose to 1.00 from 0.94 last week. Call OI fell by 11.7% WoW, while put OI declined by 6.4%.
Citigroup’s Turnaround Playbook: Core Drivers Shaping Future Performance! – Major Drivers
- Citigroup has released its fourth quarter earnings for 2024, showcasing a notable rise in net income by almost 40% to $12.7 billion for the full year, indicating positive momentum across key business segments.
- This performance was coupled with a revenue increase of 5% excluding divestitures, supported by a 17% uptick in fee revenue, and an efficiency ratio improvement by 340 basis points, which highlights the company’s operational improvements.
- However, certain macroeconomic challenges remain persistent, such as China’s slower-than-anticipated growth and Europe’s underperformance.
Odyssey Therapeutics, Inc.(ODTX): Biotech Combating Ulcerative Colitis, or UC, Files for IPO
- Biotech seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases filed its IPO on January 18th
- Lead program, OD-07656, is currently in a Phase 2a monotherapy trial for ulcerative colitis
- Potential IPO for Odyssey Therapeutics would be the first half of February
Omnicom and IPG Merger of $25.6B Combined Revenue: Market Reaction and Major US Index Implications
- The merger between Omnicom Group (OMC US) and Interpublic Group Of Companies (IPG US) aims to create a marketing powerhouse with $25.6 billion in revenue and $750 million in annual synergies.
- Deal spread narrowed due to Omnicom’s price drop, signalling market caution over post-merger performance.
- The merger’s close, expected in 2025, will impact major US indices on an intra-quarter basis.
Quanta Services Inc (PWR) – Tuesday, Oct 22, 2024
Key points
- Quanta Services has addressed issues and made investments in its electric power infrastructure solutions segment
- Surge in demand due to regulatory shifts and one-off projects has benefitted Quanta Services, but demand is expected to decrease in 2024
- Limited total addressable market and unsustainable peak expectations make Quanta Services a compelling short opportunity
This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.
